Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.02 CNY
17.56 M CNY
492.80 M CNY
404.89 M
About CHENGDU OLYMVAX BIOPHARMACEUTICALS
Sector
Industry
CEO
Shao Wen Fan
Website
Headquarters
Chengdu
Founded
2009
ISIN
CNE1000051H8
FIGI
BBG00VSF0M44
Chengdu Olymvax Biopharmaceuticals, Inc. engages in the research and development, manufacture, and sale of human-use vaccines. The company was founded on December 11, 2009 and is headquartered in Chengdu, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 688319 is 11.04 CNY — it has decreased by −3.92% in the past 24 hours. Watch CHENGDU OLYMVAX BIOPHARMACEUTICALS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange CHENGDU OLYMVAX BIOPHARMACEUTICALS stocks are traded under the ticker 688319.
688319 stock has fallen by −8.01% compared to the previous week, the month change is a 2.04% rise, over the last year CHENGDU OLYMVAX BIOPHARMACEUTICALS has showed a −30.87% decrease.
688319 reached its all-time high on Jun 8, 2021 with the price of 48.66 CNY, and its all-time low was 7.06 CNY and was reached on Apr 16, 2024. View more price dynamics on 688319 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
688319 stock is 3.33% volatile and has beta coefficient of 1.55. Track CHENGDU OLYMVAX BIOPHARMACEUTICALS stock price on the chart and check out the list of the most volatile stocks — is CHENGDU OLYMVAX BIOPHARMACEUTICALS there?
Today CHENGDU OLYMVAX BIOPHARMACEUTICALS has the market capitalization of 4.65 B, it has increased by 0.34% over the last week.
Yes, you can track CHENGDU OLYMVAX BIOPHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.
CHENGDU OLYMVAX BIOPHARMACEUTICALS is going to release the next earnings report on Apr 24, 2025. Keep track of upcoming events with our Earnings Calendar.
688319 net income for the last quarter is 31.97 M CNY, while the quarter before that showed −1.95 M CNY of net income which accounts for 1.74 K% change. Track more CHENGDU OLYMVAX BIOPHARMACEUTICALS financial stats to get the full picture.
Yes, 688319 dividends are paid annually. The last dividend per share was 0.04 CNY. As of today, Dividend Yield (TTM)% is 0.33%. Tracking CHENGDU OLYMVAX BIOPHARMACEUTICALS dividends might help you take more informed decisions.
CHENGDU OLYMVAX BIOPHARMACEUTICALS dividend yield was 0.24% in 2023, and payout ratio reached 87.76%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 18, 2024, the company has 471.00 employees. See our rating of the largest employees — is CHENGDU OLYMVAX BIOPHARMACEUTICALS on this list?
Like other stocks, 688319 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHENGDU OLYMVAX BIOPHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHENGDU OLYMVAX BIOPHARMACEUTICALS technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHENGDU OLYMVAX BIOPHARMACEUTICALS stock shows the sell signal. See more of CHENGDU OLYMVAX BIOPHARMACEUTICALS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.